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ABSTRACT 
Objective: The present study was aimed to a simple, new, rapid and highly sensitive Reverse Phase - High Performance Liquid Chromatographic 
(RP-HPLC) method has been developed and an assay was validated for the quantitative estimation of nimbolide in solid dosage form.  
Methods: The chromatographic separation was achieved on an Agilent 1200 series HPLC system C18 (250 mm x 4.6 mm x 2.5 μ) column packing by 
using isocratic mobile phase consisting of acetonitrile: water (90:10 v/v), flow rate was adjusted to 1.0 ml/min at a fixed wave length of 207 nm.  
Results: The nimbolide was eluted at 2.880 ± 0.05 min and established a dynamic range of linearity over the concentration range of 3.125-200 
ppm/ml (r2 = 0.9997 ± 0.005). The lower limit of detection and quantification was 0.007 ppm/ml and 0.021 ppm/ml respectively. The method was 
validated as per ICH guidelines. The accuracy of the method was determined by the recovery studies and the mean recovery was obtained 98.27%. 
Moreover the method was shown good reproducibility and recovery with percent relative standard deviation
Conclusion: Rapid, efficient and sensitive RP-HPLC method was developed for the estimation of nimbolide from the perspective of reducing the cost 
of analysis and time and thus by saving laboratory resources. 
 less than 2%.  
Keywords: Nimbolide, RP- HPLC, ICH guidelines. 
 
INTRODUCTION  
Azadirachta indica (Family-Meliaceae) is an important medicinal 
plant and aqueous extract of A. indica which is widely used as a 
tonic, stimulant and also against various ailments [1]. Biological 
activities of A. indica extract has been investigated intensively. In 
general, extracts of neem fruits, seeds, seed kernels, twigs, stem bark 
and root bark have been shown to possess anti-inflammatory and 
immune-stimulating activities [2-4]. Nimbolide, a chemical 
compound, is classified as a triterpenoid isolated from Azadirachta 
indica (neem tree) [5]. This compound has been shown to have some 
biological activities such as anti-feedent [6], anti-malarial [7] and 
antimicrobial activities [8, 9]. It has also been exhibited significant 
anti-cancer activity [10, 11]. 
 
Fig. 1: Structure of Nimbolide 
 
However, the toxicity of a compound has always become an issue in 
therapeutic use. It has been shown that nimbolide, when given 
through an intragastric route to experimental animals [12], did not 
show any toxicity. IUPAC name of Nimbolide is 
(4α,5α,6α,7α,15β,17α)-7,15:21,23-Diepoxy-6-hydroxy-4,8-dimethyl-
1-oxo-18,24-dinor-11, 12-secochola-2,13,20,22-tetraene-4,11-
dicarboxylic acid γ-lactone methyl ester (Mol. Formula: C27H30O7;
MATERIALS AND METHODS 
 
Mol. wt. 466.57 g/mole) in [Fig.1]. In the present study, HPLC 
method has been the development by using simple mobile phase 
which is sensitive and rapid for quantification of Nimbolide with the 
extract of Azadirachta indica as well as subsequent validation of 
developed method as per ICH guidelines [13-14]. 
Chemicals and reagents 
Nimbolide reference standard was purchased from Asthagiri Herbal 
research Foundation Centre, (Chennai, India). Acetonitrile, Methanol 
and water of HPLC grade were purchased from MERCK specialties 
Pvt Ltd. (Mumbai, India). Commercial capsules of nimbolide 
formulation were procured from local pharmacy. Neem capsule 
containing Nimbolide with labelled amount of 250 mg per capsule is 
manufactured by Himalaya Herbals, India. 
Instrumentation and chromatographic conditions 
The HPLC analysis was performed on Agilent 1200 HPLC series 
Liquid Chromatography comprising a C18 Column - 250 mm X 4.6 
mm X 2.5 micron particle size and a Prominence UV-Vis detector. A 
manually operating Rheodyne injector with 10 μL sample loop was 
equipped with the HPLC system. The HPLC system was equipped 
with “Spinchrom” data acquisition software. The mobile phase was 
consisting of Acetonitrile and water in the ratio of 90:10 v/v. These 
were filtered through 0.45μm membrane filter and degassed by 
sonication before use. The mobile phase was pumped isocratically in 
a flow rate 1.0 ml/min during analysis at ambient temperature. The 
total run time was set at 5.0 min, eluent was monitored at 207 nm 
and the base line was continuously monitored during the process. 
Preparation of stock and working standard solution of 
nimbolide 
About 25 mg of Nimbolide were weighed accurately and dissolved in 
100 ml of diluent by means of sonicated for 15 min and filter 
through Whatman filter paper. Pipette out 1.0 ml from the stock 
solution and diluted up to10 ml with the same solvent (25 ppm/ml).  
Preparation of sample solution 
Twenty capsules (Neem) were weighed accurately and powder 
equivalent to 25 mg containing Nimbolide and transfer into 100 ml 
volumetric flask. By adding 70 ml of diluent, it was placed in an ultra 
sonication bath until dissolution was complete. Same solvent was 
added to bring up the volume to 100 ml. Pipette out 1.0 ml of the 
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sample solution into a 10 ml volumetric flask and dilute up to the 
mark and mix well. The resulting solution was filtered using 0.2 μm 
filter and degassed by sonication. The resulting solution will give a 
concentration of approximately 25 ppm/ml. 
Selection of wavelength  
The UV spectrum of diluted solutions of various concentrations of 
nimbolide in mobile phase was recorded using UV spectrophotometer.  
 
 
Fig. 2: Absorption spectra of Nimbolide (25 ppm/ml) 
The wavelength of maximum absorbance was observed at 207 nm. This 
wavelength was used for detection of nimbolide. 
Calibration curve for nimbolide 
Seven different concentrations of Nimbolide were analyzed and their 
calibration curve was constructed in the specified concentration 
range (3.125-200 ppm/ml). The calibration plots were made by 
replicate analysis (n = 6) at all concentration levels. Ten micro lot 
quantity of the dilution were injected each time into the column at a 
flow rate of 1.0 ml/min. The nimbolide in the elutes was monitored 
at 207 nm.  
The results were presented in Table 1 and the corresponding 
standard chromatograms of nimbolide have been depicted between 
Fig. 4 and Fig. 10. From these chromatograms the mean peak areas 
were calculated and a plot of concentration over the peak area was 
constructed. The regression of the plot was computed by least 
squares regression method and is presented in Fig. 3. The data of 
regression analysis are presented in Table 2.  
Assay of nimbolide in neem capsule 
The proposed method was applied for the assay of Nimboide 
pharmaceutical dosage form. The drug content was calculated as an 
average of six determination and results of the assay are shown in Table 
6. The results were close to the labelled value of commercial capsule. The 
percentage assay of nimbolide was found to be 98.972%. The sample 
chromatogram of nimbolide is shown in Fig. 12. 
 
Table 1: Calibration data of the proposed HPLC method for estimation of Nimbolide 
S. No. Concentration in ppm Retention time Peak Area % RSD 
1 3.125 2.880 103465.3 0.8796 
2 6.25 2.887 200726 1.3639 
3 12.5 2.880 419504 0.4569 
4 25 2.880 797974 0.1245 
5 50 2.880 1646982 0. 2266 
6 100 2.880 3459291 0.3473 
7 200 2.880 7068030 0.1678 
Slope 35,426.1822, Intercept - 51,970.2950, Correlation Coefficient 0.9997 
 
Table 2: Linear regression data of the proposed HPLC method of Nimbolide 
Parameter Method 
Detection of wavelength  UV at 207 nm 
Linearity range  3.125- 200 ppm/ml 
Regression equation (Y= a - bX) Y= 51,970.29 + 35,426.18 
Slope(b)  35,426.18 
Intercept(a)  -51,970.29 




Fig. 3: Calibration plot of Nimbolide 
Fig. 4: Standard Chromatogram of 
Nimbolide 3.125 ppm/ml 
Farooqui et al. 
Int J Pharm Pharm Sci, Vol 6, Issue 9, 432-437 
434 
  
Fig. 5: Standard Chromatogram of Nimbolide 6.25 ppm/ml 
 
Fig. 6: Standard Chromatogram of Nimbolide 12.5 ppm/ml 
 
  
Fig. 7: Standard Chromatogram of Nimbolide 25 ppm/ml 
 
Fig. 8: Standard Chromatogram of Nimbolide 50 ppm/ml 
 
  
Fig. 9: Standard Chromatogram of Nimbolide 100 ppm/ml 
 
Fig. 10: Standard Chromatogram of Nimbolide 200 ppm/ml 
 
  
Fig. 11: Chromatogram for placebo Fig. 12: Chromatogram of Market Formulation 
 
 
Method validation: The method was validated as per the 
parameters like accuracy, precision, robustness, LOD, LOQ and 
system suitability by the following procedures:  
Precision: The precision was examined by performing the intra-day and 
inter-day assays of six replicate injections.  
The inter-day precision was assayed on two consecutive days by two 
different analysts. The percent relative standard deviation (% RSD) 
was calculated which is within the acceptable criteria of not more 
than 2.0. The intra-day and inter-day precision results are shown in 
Table 3 and Table 4 respectively.  
 
Table 3: System Precision 
S. No. Injection Retention Time Peak Area Average  SD %RSD 





2 Injection 2 2.887 6866262 
3 Injection 3 2.880 6874227 
4 Injection 4 2.880 6865277 
5 Injection 5 2.887 6878709 
6 Injection 6 2.880 6994160 
 
Table 4: Intermediate Precision 
S. No. Analyst Retention Time Area 1 Area 2 Average Area SD %RSD* 
1 1 2.82 7155900 7149312 7152606 131501.71 1.81 
2 2 2.81 7332256.00 7344899 7338578 
*Acceptance criteria < 2 
 
Table 5: LOD LOQ 
S. No. Sample Retention 
Time 
Peak Area Average %RSD LOD LOQ 
1 Injection 1 2.887 219219 219474 0.336 0.007 0.021 
2 Injection 2 2.887 219269 
3 Injection 3 2.880 220144 
4 Injection 4 2.887 218253 
5 Injection 5 2.887 220276 
6 Injection 6 2.887 219683 
 
Table 6: Assay results of Nimbolide Formulation 
Formulation Labeled Amount Amount found % Assay 
Neem capsule (Himalaya Herbals) 250mg/cap 247.43 mg/cap 98.972 
 
Table 7: Optimized chromatographic conditions and system suitability parameters of  Proposed-HPLC method for Nimbolide 
Parameters Chromatographic Conditions 
Instrument Agilent 1200 series LC system 
Column 250 mm X 4.6 mm X 2.5 μ  
Detector UV detector 
Mobile phase 90:10 (Acetonitrile-water) 
Flow rate 1 ml/min 
Run time 5 min 
Temperature Ambient temperature 
Volume of Injection loop 10 μl 
Retention time 2.880 min 
Theoretical Plates 9098 
Trailing Factor 1.46 
 
Limit of detection and limit of quantification  
The LOD and LOQ were determined by kD/S where k is constant (3.3 
for LOD and 10 for LOQ), SD is the standard deviation of the 
analytical signal and s is the slope of the concentration/response 
graph. The LOD and LOQ values are presented in Table 5. The results 
of LOD and LOQ supported the sensitivity of the developed method. 
Specificity:: The specificity of the method was determined by 
observing interference of any encountered ingredients present in 
the formulations. The test results obtained were compared with the 
results of those obtained for standard drug. It was shown that those 
ingredients were not interfering with the developed method. 
Furthermore the well-shaped peaks also indicate the specificity of 
the method. The results for specificity are tabulated in Table 8. The 
chromatogram for placebo indicating the specificity of developed 
method is presented in Fig. 11. 
Robustness: The robustness test aimed to examine the sources 
potentially subject to variations through evaluation of one or a set of 
responses inherent to the method. In this sense, the analyst, the 
wavelength (± 2) the column temperature (15 and 20˚C) and the 
flow rate (0.9 and 1.1 ml/ min) were deliberately altered. Mean and 
SD were calculated for each peak and % RSDs was calculated for 
each component during each change. The results for robustness 
study in Table 9 indicated that the small change in the conditions did 
not significantly affect the determination of Nimbolide 
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Accuracy 
The accuracy of the method was determined by calculating the 
recoveries of Nimbolide by the method of standard addition. A 
known amount of standard (50%, 100% and 150%) was added to 
pre analyzed sample solution and the amount of the standard was 
estimated by measuring the peak areas and by fitting these values to 
the straight-line equation of calibration curve. The recovery results 
for accuracy study of Nimbolide are presented in Table 10. 
System suitability  
The chromatographic systems used for analysis must pass the 
system suitability limits before sample analysis. Set up the 
chromatographic system; allow the HPLC system to stabilize for 30 
min. Inject blank preparation (single injection) and standard 
preparation (at least six replicates) and record the chromatograms 
to evaluate the system suitability parameters like tailing factor [NMT 
1.5], theoretical plate count [NLT 3000] and % RSD for peak area of 
six replicate injections of Nimbolide standard [%RSD NMT 2.0]. The 
system suitability data is reported in Table 11. 
RESULT AND DISCUSSION  
A simple HPLC method was adopted for the determination of 
Nimbolide in herbal formulation. To optimize the proposed HPLC 
method, all of the experimental conditions were investigated. To 
optimize the mobile phase, different systems were tried for 
chromatographic separation of the components. The best resolution 
was achieved using a mobile phase consisting of acetonitrile - water 
in the ratio of 90:10 v/v, which gave satisfactory result with sharp 
well defined and resolved peak with minimum tailing. The 
absorption spectrum of Nimbolide is shown in Fig. 2. The 
wavelength 207 nm was used for quantification of sample. The 
calibration curves (n=3) constructed for the Nimbolide were linear 
over the concentration range 3.125-200 ppm/ml of Nimbolide. Peak 
areas of the Nimbolide were plotted versus the concentration and 
linear regression analysis performed on the resultant curve.  
The coefficients of determination 0.9997 for Nimbolide with % RSD 
values ranging from 0.1245 to 2% across the concentration range 
studied were obtained following linear regression analysis Table 2. 
 
Table 8: Specificity Study for Nimbolide 
Name of the solution Retention time 
Mobile phase  No Peak 
Placebo No Peak 
Nimbolide 25 ppm/ml 2.880 min. 
 



















1 Wavelength (nm) 205 2.88 7035815 9319 1.37 9169.39 0.14 
207 2.88 7245592 9326 1.30 131501.7 0.18 
209 2.88 7128595 9349 1.44 9051.05 0.13 
2 Temperature (˚C) 15 2.92 7828836.67 8329 1.26 104813.05 1.26 
20 2.88 7245592 9326 1.30 131501.7 0.18 
25 2.89 7485205 8959 1.45 8762.33 1.37 
3 Flow Rate 
(ml/min) 
0.9 3.2 7841481 9954 1.34 6189.99 0.08 
1.0 2.88 7245592 9326 1.30 131501.7 0.18 
1.1 2.62 6653009 8825 1.30 619.06 0.01 
 * Plate count > 3000 
 
Table 10: Recovery Study of Nimbolide added to preanalysed sample using the Proposed HPLC method (n=3) 
% Concentration 
(at specification level) 




% recovery Mean% recovery %RSD 
50 1647387 1.0 0.98 98.00  0.23 
100 3467234 2.0 1.97 98.50 98.27 0.34 
150 5015587 3.0 2.95 98.33  0.19 
 
Table 11: System Suitability 
Parameters Nimbolide 
Linearity range (ppm) 3.125 to 200 
Slope  35426.1822 
Intercept  -51970.295 
Correlation coefficient (r2 0.9997 ) 
Theoretical plate  9098.0 
Retention time (min) 2.88 
Tailing factor 1.46 
% RSD 0.75 
 
The precision result of the solution at medium concentration is 
presented in Table 4, and it was shown that the RSD values of 
retention time were less than 1%, while the RSD values of peak area 
were less than 2 % both for intra-day assay and inter-day assay 
precision. The LOD and LOQ were found to be 0.007 ppm/ml and 
0.021 ppm/ml respectively for Nimbolide.  
The robustness study indicated that selected factor remained 
unaffected by small variation of these parameters. To ensure the 
insensitivity of the developed HPLC method to minor changes in the 
experimental conditions, it is important to demonstrate its 
robustness. None of the alterations caused a significant change in, 
retention time and theoretical plates. 
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A system suitability test was performed to evaluate the 
chromatographic parameter (retention time, number of theoretical 
plate and tailing factor) before the validations run (Table 11). The 
accuracy was studied by the standard addition technique. Three 
different levels of standard were added to the previously analyzed 
samples, each level being repeated thrice. The percentage recovery 
of Nimbolide was 98.27 in herbal formulation as shown in Table 10. 
CONCLUSION  
The developed HPLC method has various advantages like less 
retention time, good peak symmetry and phenomenal linearity, 
highly sensitive, simple, precise and robust for the analysis of 
Nimbolide. Since the proposed mobile phase effectively resolves 
nimbolide, the method can be used for qualitative as well as 
quantitative analysis of nimbolide in herbal formulations. The drug 
solutions employed in the study were stable up to 48 hours. These 
attribute the high quality of the method. The RSD values for all 
parameters were found to be less than 2, which indicates the validity 
of method and results obtained by this method is with fair 
agreement. The proposed method can be used for the routine 
analysis of Nimbolide in bulk preparations of the drug and in 
pharmaceutical dosage forms for routine application in quality 
control laboratories. 
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